Given that the IGF1R gene variant has been shown to increase susceptibility for seropositive SS-nL and SS-L, we next sought to explore whether IGF1R expression is altered in peripheral blood and MSG tissues from these patients. Here, IGF1R is linked to synovial sarcoma.